Interní Med. 2001; 3(8): 369-371

Chronická aortální regurgitace - kdy sledovat, kdy léčit, kdy operovat?

MUDr. Jana Gandalovičová
II. interní klinika kardiologie a angiologie 1. LF UK a VFN, Praha

Published: December 31, 2001  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gandalovičová J. Chronická aortální regurgitace - kdy sledovat, kdy léčit, kdy operovat? Interní Med. 2001;3(8):369-371.

Z materiálů prezentovaných během přednáškového cyklu Controversies in Cardiology při Cardiovascular Institute, The Mount Sinai Medical Center, NYU.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Singh JP, et al. Prevalence and clinical determinants of mitral, tricuspidal and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 1999, 83: 897-902. Go to original source... Go to PubMed...
    2. Fligner CL, Reichenbach DD. Pathology and Etiology of Heart Disease. Otto CM, ed.Valvular heart disease. Philadelphia: W. B. Saunders, 1999: 13-42.
    3. Bonow RO, Lakatos E et al. Seriál long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function.Circulation 1991, 84: 1625-35. Go to original source... Go to PubMed...
    4. Rapaport E. Natural history of aortic and mitral valve disease. Am J cardiol, 1975, 35, 221-7. Go to original source... Go to PubMed...
    5. Bonow RO, Carabello B et al. ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Assocoation Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J Heart Valve Dis 1998, 7: 672-707. Go to PubMed...
    6. Dujardin KS, et al. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation 1999, 99: 1851-7. Go to original source... Go to PubMed...
    7. Klodas E, Enriquez-Sarano M et al. Aortic regurgitation complicated by extreme left ventricular dilatation: long-term outcome after surgical correction. J Am Coll Cardiol 1996, 27: 670-7. Go to original source... Go to PubMed...
    8. Bonow RO, Rosing DR et al. Reversal of left ventricular dysfunction after aortic valve replacement for chronic aortic regurgitation: influence of duration of preoperative left ventricular dysfunction. Circulation 1984, 70: 570-9. Go to original source... Go to PubMed...
    9. Henry WL, Bonow RO et al. Observations on the optimum time for operative intervention for aortic regurgitation. I. Evaluation of the results of aortic valve replacement in symptomatic patients. Circulation 1980, 61: 471-83. Go to original source... Go to PubMed...
    10. Henry WL, Bonow RO et al. Observations on the optimum time for operative intervation for aortic regurgitation. II. Serial echocardiographic evaluation of asymptomatic patients. Circulation 1980: 61: 484-92. Go to original source... Go to PubMed...
    11. Otto Cm. Principles of medical therapy for valvular heart disease. Otto CM, ed.Valvular heart disease. Philadelphia: W. B. Saunders, 1999: 116-134.
    12. Levine HJ, Gaasch WH.Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves. J Am Coll Cardiol 1996, 28: 1083-91. Go to original source... Go to PubMed...
    13. Sondergaard L, Aldershvile J et al. Vasodilatation with felodipine in chronic asymptomatic aortic regurgitation. Am Heart J 2000, 139: 667-74. Go to original source... Go to PubMed...
    14. Scognamiglio R, Rahimtoola SH, et al. Nifedipine in asympromatic patients with severe aortic regurgitation and normal left ventricular function. A Engl J Med 1994, 331: 689-94. Go to original source... Go to PubMed...
    15. Banaszewski M, Rydlewska-Sadowska W et al. Captopril or nifedipine? Comparison of rest and exercise acute effects and long-term therapy in chronic isolated asymptomatic moderate to severe aortic regurgitation. J Heart Valve Dis 1998, 7: 488-99. Go to PubMed...
    16. Bonow RO. Chronic aortic regurgitation. Role of medical therapy and optimal timing for surgery. Cardiol Clin 1998, 16: 449-61. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.